Скачать с ютуб Schizophrenia Treatment: Clozapine, LAIs, Technology & Equity with John Kane, MD & Lauren Hanna, MD в хорошем качестве

Schizophrenia Treatment: Clozapine, LAIs, Technology & Equity with John Kane, MD & Lauren Hanna, MD

In this episode, we welcome Dr. John M. Kane, Dr. Lauren Hanna, Dr. Julia Tartaglia, and Dr. Joseph Flaxer to discuss Clozapine and treatment-resistant schizophrenia.  Conflicts of Interest for this episode: Only Dr. John Kane has any potential reported conflicts of interest: Consultant to or Receives Honoraria: Alkermes, Allergan, Boehringer-Ingelheim, Cerevel, Dainippon Sumitomo, H. Lundbeck, HealthRhythms, HLS, Indivior, Intracellular Therapies, Janssen Pharmaceutical, Johnson & Johnson, LB Pharmaceuticals, Merck, Minerva, Neurocrine, Newron, Novartis, NW PharmaTech, Otsuka, Roche, Saladax, Sunovion, Teva Advisory Boards: Cerevel, Click Therapeutics, Lundbeck, Merck, Newron, Novartis, Otsuka, Sumitomo, Teva Grant Support: Lundbeck, Otsuka, Janssen, Sunovion Shareholder: Vanguard Research Group (private), LB Pharmaceuticals, Inc. (private), North Shore Therapeutics (private), MedinCell (public), Sage (public) Receives royalties Up to Date Link to Blog: https://www.psychiatrypodcast.com/psy... Join Our CME Program: https://www.psychiatrypodcast.com/cme...